Found: 1
Select item for more details and to access through your institution.
The contributing factors of resistance or sensitivity to epigenetic drugs in the treatment of AML.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 7, p. 1250, doi. 10.1007/s12094-022-02776-0
- By:
- Publication type:
- Article